Consistent with the previous studies, our present study found that Hsp22 protein level was decreased after DOX treatment in C57BL/6 mice; there is some potential for Hsp22 to be a defender in the treatment of DOX-induced cardiomyopathy. The gene discussed is HSPB8; the disease is cardiomyopathy.